Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Chronic Renal Failure

Free Subscription Articles published in Curr Opin Nephrol Hypertens Retrieve available abstracts of 62 articles: HTML format

Single Articles

March 2026
1. RHEE CM, Zisman-Ilani Y, Kalantar-Zadeh K, Nguyen DV, et al
   Continuous glucose monitoring in patients with chronic kidney disease on dialysis and with kidney transplantation.
   Curr Opin Nephrol Hypertens. 2026 Mar 6. doi: 10.1097/MNH.0000000000001169.
   PubMed     Abstract available
   
   
   January 2026
2. SHAH AD, Goldfarb DS
   Hemodiafiltration: balancing clinical efficacy with planetary health.
   Curr Opin Nephrol Hypertens. 2026 Jan 9. doi: 10.1097/MNH.0000000000001160.
   PubMed     Abstract available
   
   
   
3. SAEED F, Duberstein PR, White DB, Liu KD, et al
   Time-limited trials for acute dialysis decision-making for critically ill older patients: rationale, communication strategies, and future research.
   Curr Opin Nephrol Hypertens. 2026 Jan 6. doi: 10.1097/MNH.0000000000001155.
   PubMed     Abstract available
   
   
   
4. SHAH AD
   Home sweet home dialysis.
   Curr Opin Nephrol Hypertens. 2026;35:72-73.
   PubMed    
   
   
   December 2025
5. HERNANDEZ MF, Chang TI
   Pros and cons of lower blood pressure targets in chronic kidney disease.
   Curr Opin Nephrol Hypertens. 2025 Dec 30. doi: 10.1097/MNH.0000000000001153.
   PubMed     Abstract available
   
   
   
6. RATTANASOMPATTIKUL M, Srithongkul T, Tantisattamo E, Kalantar-Zadeh K, et al
   Indoxyl sulfate: clinical implications for anemia management in chronic kidney disease.
   Curr Opin Nephrol Hypertens. 2025 Dec 8. doi: 10.1097/MNH.0000000000001145.
   PubMed     Abstract available
   
   
   November 2025
7. ZISMAN-ILANI Y, Rhee CM, Ammary FA, Kalantar-Zadeh K, et al
   Shared decision making and decision aids in the management of kidney disease and renal replacement treatment options.
   Curr Opin Nephrol Hypertens. 2025 Nov 24. doi: 10.1097/MNH.0000000000001140.
   PubMed     Abstract available
   
   
   
8. DAI T, Shah A, Chong CC, Pham PC, et al
   Evolution of continuous renal replacement therapy scenarios and the rise of anticoagulant-free continuous veno-venous hemodiafiltration.
   Curr Opin Nephrol Hypertens. 2025 Nov 20. doi: 10.1097/MNH.0000000000001138.
   PubMed     Abstract available
   
   
   
9. TAKAHASHI R, Obi Y, Kalantar-Zadeh K, Kovesdy CP, et al
   The obesity and lipid paradoxes in chronic kidney disease: mechanisms, interventions, and future directions.
   Curr Opin Nephrol Hypertens. 2025 Nov 20. doi: 10.1097/MNH.0000000000001131.
   PubMed     Abstract available
   
   
   
10. TAKASHIMA H, Maruyama T, Abe M
    Super high-flux membrane dialyzers and mortality in patients undergoing hemodialysis.
    Curr Opin Nephrol Hypertens. 2025 Nov 11. doi: 10.1097/MNH.0000000000001134.
    PubMed     Abstract available
    
    
    
11. NERI L, Zhang H, Usvyat LA
    Artificial intelligence in kidney disease and dialysis: from data mining to clinical impact.
    Curr Opin Nephrol Hypertens. 2025 Nov 10. doi: 10.1097/MNH.0000000000001132.
    PubMed     Abstract available
    
    
    October 2025
12. HUSSEIN WF, Abra G
    Staff-assisted peritoneal dialysis in the United States: from evidence to national adoption.
    Curr Opin Nephrol Hypertens. 2025 Oct 30. doi: 10.1097/MNH.0000000000001128.
    PubMed     Abstract available
    
    
    
13. CADORE-GUZZO E, Baptise T, Shah A
    Back to the future: a review of peritoneal dialysis for acute kidney injury.
    Curr Opin Nephrol Hypertens. 2025 Oct 30. doi: 10.1097/MNH.0000000000001129.
    PubMed     Abstract available
    
    
    
14. BANSAL S, Nararyan R
    Management of peritoneal dialysis in patients with obesity.
    Curr Opin Nephrol Hypertens. 2025 Oct 24. doi: 10.1097/MNH.0000000000001124.
    PubMed     Abstract available
    
    
    
15. EL SHAMY O
    Remote monitoring in peritoneal dialysis: an underutilized tool.
    Curr Opin Nephrol Hypertens. 2025 Oct 23. doi: 10.1097/MNH.0000000000001127.
    PubMed     Abstract available
    
    
    
16. BERMUDEZ MC, El Shamy O
    Self-cannulation for home hemodialysis: a review of current practices and implementation approaches.
    Curr Opin Nephrol Hypertens. 2025 Oct 15. doi: 10.1097/MNH.0000000000001121.
    PubMed     Abstract available
    
    
    
17. HSU CM, Weiner DE, McCallum W
    Peritoneal dialysis and heart failure.
    Curr Opin Nephrol Hypertens. 2025 Oct 15. doi: 10.1097/MNH.0000000000001125.
    PubMed     Abstract available
    
    
    
18. YE WWQ, Malavade T, Bargman JM, Chan CT, et al
    Bringing medical education "home": the university health network and St. Michael's hospital home dialysis fellowship.
    Curr Opin Nephrol Hypertens. 2025 Oct 6. doi: 10.1097/MNH.0000000000001122.
    PubMed     Abstract available
    
    
    September 2025
19. MERLINO L, Tollitt J, Dunne RA, Kalra PA, et al
    Pathophysiology of cognitive impairment in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2025 Sep 15. doi: 10.1097/MNH.0000000000001117.
    PubMed     Abstract available
    
    
    July 2025
20. LIARAKOS AL, Randhay A, Wilmot EG
    Continuous glucose monitoring and automated insulin delivery systems in the management of diabetes among individuals with chronic kidney disease on dialysis.
    Curr Opin Nephrol Hypertens. 2025 Jul 15. doi: 10.1097/MNH.0000000000001106.
    PubMed     Abstract available
    
    
    
21. SKOBERNE A
    The impact of conflicts on patients with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2025 Jul 15. doi: 10.1097/MNH.0000000000001107.
    PubMed     Abstract available
    
    
    May 2025
22. KHAIRALLAH P
    Agents to treat osteoporosis in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2025 May 19. doi: 10.1097/MNH.0000000000001091.
    PubMed     Abstract available
    
    
    
23. DELANAYE P, Gama RM, Stehle T
    Impact of the choice of biomarkers and equations to estimate kidney function on the epidemiology of chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2025 May 19. doi: 10.1097/MNH.0000000000001085.
    PubMed     Abstract available
    
    
    
24. POTHULA VENKATA V, Scialla JJ
    Momentum toward patient outcome trials in chronic kidney disease-mineral bone disorder.
    Curr Opin Nephrol Hypertens. 2025 May 19. doi: 10.1097/MNH.0000000000001087.
    PubMed     Abstract available
    
    
    
25. ABU KAR S, Harris RC
    Chronic kidney disease and sex dimorphism.
    Curr Opin Nephrol Hypertens. 2025 May 15. doi: 10.1097/MNH.0000000000001093.
    PubMed     Abstract available
    
    
    
26. THEODORAKOPOULOU MP, Iatridi F, Sarafidis PA
    Aldosterone synthase inhibition in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2025 May 2. doi: 10.1097/MNH.0000000000001089.
    PubMed     Abstract available
    
    
    
27. FREIRE-FILHO WA, Dalboni MA, Elias RM
    Effects of aging on chronic kidney disease mineral and bone disorder.
    Curr Opin Nephrol Hypertens. 2025 May 2. doi: 10.1097/MNH.0000000000001084.
    PubMed     Abstract available
    
    
    April 2025
28. MARTINEZ-ROJAS MA, Bobadilla NA
    Sodium-glucose cotransporter 2 inhibitors: a novel approach to prevent the transition from acute kidney injury to chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2025 Apr 23. doi: 10.1097/MNH.0000000000001080.
    PubMed     Abstract available
    
    
    
29. SPENCER S, Bhandari S
    Optimizing renin-angiotensin-aldosterone inhibition in advanced chronic kidney disease: balancing benefits and risks.
    Curr Opin Nephrol Hypertens. 2025 Apr 8. doi: 10.1097/MNH.0000000000001076.
    PubMed     Abstract available
    
    
    
30. DUQUE EJ, Giachelli C, Moyses RMA
    The role of osteopontin in chronic kidney disease-mineral bone disorder.
    Curr Opin Nephrol Hypertens. 2025 Apr 2. doi: 10.1097/MNH.0000000000001074.
    PubMed     Abstract available
    
    
    March 2025
31. GOLDFARB DS
    The hemodialysis unit: the place where everybody knows your name.
    Curr Opin Nephrol Hypertens. 2025;34:129-130.
    PubMed    
    
    
    February 2025
32. LEDUC C, Tomisawa N, Ronco C, Kalantar-Zadeh K, et al
    The history and future of online hemodiafiltration and online solutions in North America.
    Curr Opin Nephrol Hypertens. 2025 Feb 19. doi: 10.1097/MNH.0000000000001051.
    PubMed     Abstract available
    
    
    January 2025
33. RHEE CM, Kovesdy CP, Unruh M, Crowley S, et al
    Incremental hemodialysis transition in veterans and nonveterans with kidney failure.
    Curr Opin Nephrol Hypertens. 2025;34:33-40.
    PubMed     Abstract available
    
    
    
34. TANTISATTAMO E, Hanna RM, Kalantar-Zadeh K
    Implementing novel diagnostic and therapeutic strategies to improve population health outcomes and equity in kidney disease, dialysis therapies, and transplantation.
    Curr Opin Nephrol Hypertens. 2025;34:1-3.
    PubMed    
    
    
    
35. YERRAM P, Edwards D, Norris KC, Molony D, et al
    Practicing health equity in kidney care by establishing improved access to timely disease management and kidney replacement therapy options: from providers to patients.
    Curr Opin Nephrol Hypertens. 2025;34:48-54.
    PubMed     Abstract available
    
    
    
36. SEGHERS F, Tintillier M, Morelle J
    Recent advances in the understanding of the peritoneal membrane.
    Curr Opin Nephrol Hypertens. 2025;34:77-84.
    PubMed     Abstract available
    
    
    
37. SHAH AD
    Bringing the end-stage kidney disease life plan home.
    Curr Opin Nephrol Hypertens. 2025;34:67-68.
    PubMed    
    
    
    
38. NARASAKI Y, Rhee CM, Kalantar-Zadeh K, Rastegar M, et al
    Why protein-energy wasting leads to faster progression of chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2025;34:55-66.
    PubMed     Abstract available
    
    
    
39. BROWN CO, Pham PC, Shah A, Dukkipati R, et al
    Population health strategies for health equity in chronic kidney disease management.
    Curr Opin Nephrol Hypertens. 2025;34:41-47.
    PubMed     Abstract available
    
    
    December 2024
40. MARTIN D, Brewster P, Crowley ST
    Preparing for stormy weather: building VA health system resilience for dialysis emergency preparedness in the era of climate change.
    Curr Opin Nephrol Hypertens. 2024 Dec 18. doi: 10.1097/MNH.0000000000001054.
    PubMed     Abstract available
    
    
    
41. WATNICK S
    Use of water in dialysis and its impact on the environment.
    Curr Opin Nephrol Hypertens. 2024 Dec 18. doi: 10.1097/MNH.0000000000001058.
    PubMed     Abstract available
    
    
    
42. WALLACH JD, Medaura JA, Stern L
    Home dialysis: there's no place like home.
    Curr Opin Nephrol Hypertens. 2024 Dec 16. doi: 10.1097/MNH.0000000000001056.
    PubMed     Abstract available
    
    
    
43. 
    Population Health Strategies for Health Equity in Chronic Kidney Disease Management: Retraction.
    Curr Opin Nephrol Hypertens. 2024 Dec 10. doi: 10.1097/MNH.0000000000001055.
    PubMed    
    
    
    November 2024
44. KIM B, Kanchi R, Titus AR, Grams ME, et al
    Built environment and chronic kidney disease: current state and future directions.
    Curr Opin Nephrol Hypertens. 2024 Nov 22. doi: 10.1097/MNH.0000000000001048.
    PubMed     Abstract available
    
    
    
45. BROWN CO, Pham PC, Shah A, Dukkipati R, et al
    Population health strategies for health equity in chronic kidney disease management.
    Curr Opin Nephrol Hypertens. 2024 Nov 21. doi: 10.1097/MNH.0000000000001044.
    PubMed     Abstract available
    
    
    
46. SHRINGI S, Shah AD
    The cardiovascular unphysiology of thrice weekly hemodialysis.
    Curr Opin Nephrol Hypertens. 2024 Nov 6. doi: 10.1097/MNH.0000000000001037.
    PubMed     Abstract available
    
    
    
47. PECCE A, Belhumeur L, Nadeau-Fredette AC
    Staying home when peritoneal dialysis ends: the integrated home dialysis approach.
    Curr Opin Nephrol Hypertens. 2024 Nov 4. doi: 10.1097/MNH.0000000000001034.
    PubMed     Abstract available
    
    
    October 2024
48. SHAMY OE, Sloand JA
    Automation and innovation in home hemodialysis machines.
    Curr Opin Nephrol Hypertens. 2024 Oct 30. doi: 10.1097/MNH.0000000000001033.
    PubMed     Abstract available
    
    
    
49. AL SAHLAWI M, Chan CT, Perl J
    Infection prevention in home dialysis.
    Curr Opin Nephrol Hypertens. 2024 Oct 15. doi: 10.1097/MNH.0000000000001032.
    PubMed     Abstract available
    
    
    
50. QUINN RR, Oliver MJ
    Recent advances in peritoneal dialysis catheter placement: the association between method of insertion, operator, and prior abdominal surgery and outcomes.
    Curr Opin Nephrol Hypertens. 2024 Oct 7. doi: 10.1097/MNH.0000000000001031.
    PubMed     Abstract available
    
    
    September 2024
51. IYENGAR A, Kalyesubula R, Darwish R, Luyckx VA, et al
    International equity in access to home dialysis.
    Curr Opin Nephrol Hypertens. 2024 Sep 13. doi: 10.1097/MNH.0000000000001027.
    PubMed     Abstract available
    
    
    August 2024
52. VAN MIL D, Kieneker LM, Heerspink HJL, Gansevoort RT, et al
    Screening for chronic kidney disease: change of perspective and novel developments.
    Curr Opin Nephrol Hypertens. 2024 Aug 14. doi: 10.1097/MNH.0000000000001016.
    PubMed     Abstract available
    
    
    
53. PEPIN M, Levassort H, Massy ZA
    The impact of chronic kidney disease on cognitive function.
    Curr Opin Nephrol Hypertens. 2024 Aug 13. doi: 10.1097/MNH.0000000000001017.
    PubMed     Abstract available
    
    
    July 2024
54. FRASER SDS, Phillips T
    Quality of life in people with chronic kidney disease: focusing on modifiable risk factors.
    Curr Opin Nephrol Hypertens. 2024 Jul 23. doi: 10.1097/MNH.0000000000001013.
    PubMed     Abstract available
    
    
    
55. DANZIGER J
    Synergistic susceptibility to environmental lead toxicity in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2024 Jul 18. doi: 10.1097/MNH.0000000000000991.
    PubMed     Abstract available
    
    
    June 2024
56. TUTTLE M, Sarnak MJ, Navaneethan SD
    Therapeutic approaches for pulmonary hypertension in patients with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2024 Jun 20. doi: 10.1097/MNH.0000000000001008.
    PubMed     Abstract available
    
    
    April 2024
57. EVENEPOEL P, Jorgensen HS
    Skeletal parathyroid hormone hyporesponsiveness: a neglected, but clinically relevant reality in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2024 Apr 24. doi: 10.1097/MNH.0000000000000992.
    PubMed     Abstract available
    
    
    
58. FAIVRE A, de Seigneux S
    The role of hypoxia in chronic kidney disease: a nuanced perspective.
    Curr Opin Nephrol Hypertens. 2024 Apr 11. doi: 10.1097/MNH.0000000000000989.
    PubMed     Abstract available
    
    
    
59. HUISH S, Sinha S
    New therapeutic perspectives for vascular and valvular calcifications in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2024 Apr 5. doi: 10.1097/MNH.0000000000000985.
    PubMed     Abstract available
    
    
    March 2024
60. ALEXIUK M, Tangri N
    Prediction models for earlier stages of chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2024 Mar 1. doi: 10.1097/MNH.0000000000000981.
    PubMed     Abstract available
    
    
    February 2024
61. HOLLIDAY MW JR, Frost L, Navaneethan SD
    Emerging evidence for glucagon-like peptide-1 agonists in slowing chronic kidney disease progression.
    Curr Opin Nephrol Hypertens. 2024 Feb 26. doi: 10.1097/MNH.0000000000000976.
    PubMed     Abstract available
    
    
    
62. HUNDEMER GL, Akbari A, Sood MM
    Has the time come for age-adapted glomerular filtration rate criteria to define chronic kidney disease: how soon is now?
    Curr Opin Nephrol Hypertens. 2024 Feb 26. doi: 10.1097/MNH.0000000000000971.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Renal Failure is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum